ConductScience.org, home

Paper11564

Histamine H2-receptor antagonists in the treatment of duodenal ulcers.

Bank S and 8 others. S Afr Med J, 1976. Cited by 55 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Histamine H2-receptor antagonists in the treatment of duodenal ulcers. Papers, record 11564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11564

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histamine H2-receptor antagonists in the treatment of duodenal ulcers.
PubMed
Journal
S Afr Med J
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2018-11-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bank SS
2Barbezat GOG O
3Novis BHB H
4Tim LOL O
5Odes HSH S
6Helman CC
7Narunsky LL
8Duys PJP J
9Marks INI N

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Duodenal UlcerMajor topic
Histamine H2 AntagonistsMajor topic
Antacids
Clinical Trials as Topic
Gastric Juice
Humans
Metiamide
Placebos
Wound Healing

Source PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
8,020,825Duodenal ulcer pain--the role of acid and inflammation.Gut1994https://conductscience.org/library/papers/8020825PubMed
7,215,949Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment.Gut1981https://conductscience.org/library/papers/7215949PubMed
6,284,459Ranitidine in duodenal ulcer: incidence of healing and effect of smoking.Dig Dis Sci1982https://conductscience.org/library/papers/6284459PubMed
6,113,192Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.Gut1981https://conductscience.org/library/papers/6113192PubMed
2,649,413Acid induced duodenal ulcer pain: the influence of symptom status and the effect of an antispasmodic.Gut1989https://conductscience.org/library/papers/2649413PubMed
627,203Role of cimetidine in gastrointestinal disease: present status and future potential.Drugs1978https://conductscience.org/library/papers/627203PubMed
487,912A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer.Dig Dis Sci1979https://conductscience.org/library/papers/487912PubMed
367,885Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial.Gut1979https://conductscience.org/library/papers/367885PubMed
344,157Effect of prolonged cimetidine therapy on gastric acid secretion in man.Gut1978https://conductscience.org/library/papers/344157PubMed
342,231Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.Drugs1978https://conductscience.org/library/papers/342231PubMed
17,229Drugs for peptic ulcer.World J Surg1977https://conductscience.org/library/papers/17229PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11564

GET https://conductscience.org/api/papers/v1/11564/authors